Everly Bio harnesses novel multisystem molecular insights and advanced computational biology for unprecedented decision support in fertility. Infertility is a growing global issue, that affects 1 in 6 couples. The demand for fertility services has reached unprecedented levels. However, the market has been slow to innovate, with current solutions being ineffective. Everly Bio aims to revolutionize the methodology of infertility treatments, enabling shorter time to pregnancy, increasing accessibility. Combining noninvasive technology with molecular insights and AI. Our solution serves as a platform for diagnosis and intervention.